MovDisordV3, PascalFrancis, Curation, bibRecord, 001C76

Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results

Identifieur interne : 001C76 ( PascalFrancis/Curation ); précédent : 001C75; suivant : 001C77

Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results

Auteurs : Christopher G. Goetz [États-Unis] ; Barbara C. Tilley [États-Unis] ; Stephanie R. Shaftman [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Wemer Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Matthew B. Stem [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lane [Canada] ; Andrew Lees [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Le Witt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis]

Source :

Movement disorders [ 0885-3185 ] ; 2008.

RBID : Pascal:09-0038025

Descripteurs français

Pascal (Inist)
- Maladie de Parkinson, Syndrome myélodysplasique, Pathologie du système nerveux, Révision, Echelle d'évaluation.

English descriptors

KwdEn :
- Evaluation scale, Myelodysplastic syndrome, Nervous system diseases, Parkinson disease, Revision.

Abstract

We present a clinimetric assessment of the Movement Disorder Society (MDS)-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UDPRS Task Force revised and expanded the UPDRS using recommendations from a published critique. The MDS-UPDRS has four parts, namely, I: Non-motor Experiences of Daily Living; II: Motor Experiences of Daily Living; III: Motor Examination; IV: Motor Complications. Twenty questions are completed by the patient/caregiver. Item-specific instructions and an appendix of complementary additional scales are provided. Movement disorder specialists and study coordinators administered the UPDRS (55 items) and MDS-UPDRS (65 items) to 877 English speaking (78% non-Latino Caucasian) patients with Parkinson's disease from 39 sites. We compared the two scales using correlative techniques and factor analysis. The MDS-UPDRS showed high intemal consistency (Cronbach's alpha = 0.79-0.93 across parts) and correlated with the original UPDRS (p = 0.96). MDS-UPDRS across-part correlations ranged from 0.22 to 0.66. Reliable factor structures for each part were obtained (comparative fit index > 0.90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 23`
A06				`@2 15`
A08	`01`	`1`	`ENG`	`@1 Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results`
A11	`01`	`1`		`@1 GOETZ (Christopher G.)`
A11	`02`	`1`		`@1 TILLEY (Barbara C.)`
A11	`03`	`1`		`@1 SHAFTMAN (Stephanie R.)`
A11	`04`	`1`		`@1 STEBBINS (Glenn T.)`
A11	`05`	`1`		`@1 FAHN (Stanley)`
A11	`06`	`1`		`@1 MARTINEZ-MARTIN (Pablo)`
A11	`07`	`1`		`@1 POEWE (Wemer)`
A11	`08`	`1`		`@1 SAMPAIO (Cristina)`
A11	`09`	`1`		`@1 STEM (Matthew B.)`
A11	`10`	`1`		`@1 DODEL (Richard)`
A11	`11`	`1`		`@1 DUBOIS (Bruno)`
A11	`12`	`1`		`@1 HOLLOWAY (Robert)`
A11	`13`	`1`		`@1 JANKOVIC (Joseph)`
A11	`14`	`1`		`@1 KULISEVSKY (Jaime)`
A11	`15`	`1`		`@1 LANE (Anthony E.)`
A11	`16`	`1`		`@1 LEES (Andrew)`
A11	`17`	`1`		`@1 LEURGANS (Sue)`
A11	`18`	`1`		`@1 LE WITT (Peter A.)`
A11	`19`	`1`		`@1 NYENHUIS (David)`
A11	`20`	`1`		`@1 OLANOW (C. Warren)`
A11	`21`	`1`		`@1 RASCOL (Olivier)`
A11	`22`	`1`		`@1 SCHRAG (Anette)`
A11	`23`	`1`		`@1 TERESI (Jeanne A.)`
A11	`24`	`1`		`@1 VAN HILTEN (Jacobus J.)`
A11	`25`	`1`		`@1 LAPELLE (Nancy)`
A14	`01`			`@1 Department of Neurological Sciences, Rush University Medical Center @2 Chicago, Illinois @3 USA @Z 1 aut. @Z 4 aut. @Z 17 aut.`
A14	`02`			`@1 Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina @2 Charleston, South Carolina @3 USA @Z 2 aut. @Z 3 aut.`
A14	`03`			`@1 Department of Neurology, Columbia University @2 New York, New York @3 USA @Z 5 aut.`
A14	`04`			`@1 Neuroepidemiology Unit and CIBERNED, Carlos III Institute of Health @2 Madrid @3 ESP @Z 6 aut.`
A14	`05`			`@1 Department of Neurology, Innsbruck Medical University @2 Innsbruck @3 AUT @Z 7 aut.`
A14	`06`			`@1 Department of Pharmacology, Faculdade de Medicina de Lisboa @2 Lishoa @3 PRT @Z 8 aut.`
A14	`07`			`@1 Department of Neurology, University of Pennsylvania @2 Philadelphia, Pennsylvania @3 USA @Z 9 aut.`
A14	`08`			`@1 Department of Neurology, Philipps-University @2 Marburg @3 DEU @Z 10 aut.`
A14	`09`			`@1 Department of Neurology, Hôpital de la Salpêtrière @2 Paris @3 FRA @Z 11 aut.`
A14	`10`			`@1 Department of Neurology, University of Rochester @2 Rochester, New York @3 USA @Z 12 aut.`
A14	`11`			`@1 Department of Neurology, Baylor College of Medicine @2 Houston, Texas @3 USA @Z 13 aut.`
A14	`12`			`@1 Department of Neurology and CIBERNED, Sant Pau Hospital @2 Barcelona @3 ESP @Z 14 aut.`
A14	`13`			`@1 Division of Neurology, University of Toronto @2 Toronto @3 CAN @Z 15 aut.`
A14	`14`			`@1 Reta Lila Weston Institute of Neurological Studies, University College @2 London @3 GBR @Z 16 aut.`
A14	`15`			`@1 Department of Neurology, Wayne State University @2 Detroit, Michigan @3 USA @Z 18 aut.`
A14	`16`			`@1 Deparonent of Neurology and Rehabilitation, University of, Illinois @2 Chicago, Illinois @3 USA @Z 19 aut.`
A14	`17`			`@1 Department of Neurology, Mount Sinai School of Medicine @2 New York, New York @3 USA @Z 20 aut.`
A14	`18`			`@1 Department of Neuroscience, Mount Sinai School of Medicine @2 New York, New York @3 USA @Z 20 aut.`
A14	`19`			`@1 Laboratoire de Pharmacologie Médicale et Clinique, Toulouse University @2 Toulouse @3 FRA @Z 21 aut.`
A14	`20`			`@1 Department of Clinical Neurosciences, University College @2 London @3 GBR @Z 22 aut.`
A14	`21`			`@1 Stroud Center, Division of General Medicine and Psychiatric Institute, Columbia University @2 New York, New York @3 USA @Z 23 aut.`
A14	`22`			`@1 Department of Neurology, Leiden University @2 Leiden @3 NLD @Z 24 aut.`
A14	`23`			`@1 Division of Preventive and Behavioral Medicine, University of Massachusetts @2 Worcester, Massachusetts @3 USA @Z 25 aut.`
A17	`01`	`1`		`@1 Movement Disorder Society UPDRS Revision Task Force @3 INC`
A20				`@1 2129-2170`
A21				`@1 2008`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000185020710040`
A44				`@0 0000 @1 © 2009 INIST-CNRS. All rights reserved.`
A45				`@0 14 ref.`
A47	`01`	`1`		`@0 09-0038025`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 We present a clinimetric assessment of the Movement Disorder Society (MDS)-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UDPRS Task Force revised and expanded the UPDRS using recommendations from a published critique. The MDS-UPDRS has four parts, namely, I: Non-motor Experiences of Daily Living; II: Motor Experiences of Daily Living; III: Motor Examination; IV: Motor Complications. Twenty questions are completed by the patient/caregiver. Item-specific instructions and an appendix of complementary additional scales are provided. Movement disorder specialists and study coordinators administered the UPDRS (55 items) and MDS-UPDRS (65 items) to 877 English speaking (78% non-Latino Caucasian) patients with Parkinson's disease from 39 sites. We compared the two scales using correlative techniques and factor analysis. The MDS-UPDRS showed high intemal consistency (Cronbach's alpha = 0.79-0.93 across parts) and correlated with the original UPDRS (p = 0.96). MDS-UPDRS across-part correlations ranged from 0.22 to 0.66. Reliable factor structures for each part were obtained (comparative fit index > 0.90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Syndrome myélodysplasique @5 02`
C03	`02`	`X`	`ENG`	`@0 Myelodysplastic syndrome @5 02`
C03	`02`	`X`	`SPA`	`@0 Mielodisplastico síndrome @5 02`
C03	`03`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 03`
C03	`03`	`X`	`ENG`	`@0 Nervous system diseases @5 03`
C03	`03`	`X`	`SPA`	`@0 Sistema nervioso patología @5 03`
C03	`04`	`X`	`FRE`	`@0 Révision @5 09`
C03	`04`	`X`	`ENG`	`@0 Revision @5 09`
C03	`04`	`X`	`SPA`	`@0 Revisión @5 09`
C03	`05`	`X`	`FRE`	`@0 Echelle d'évaluation @5 10`
C03	`05`	`X`	`ENG`	`@0 Evaluation scale @5 10`
C03	`05`	`X`	`SPA`	`@0 Escala evaluación @5 10`
C07	`01`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Hémopathie maligne @2 NM @5 42`
C07	`05`	`X`	`ENG`	`@0 Malignant hemopathy @2 NM @5 42`
C07	`05`	`X`	`SPA`	`@0 Hemopatía maligna @2 NM @5 42`
C07	`06`	`X`	`FRE`	`@0 Cancer @2 NM`
C07	`06`	`X`	`ENG`	`@0 Cancer @2 NM`
C07	`06`	`X`	`SPA`	`@0 Cáncer @2 NM`
N21				`@1 026`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001043

Links to Exploration step

Pascal:09-0038025

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results</title>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Tilley, Barbara C" sort="Tilley, Barbara C" uniqKey="Tilley B" first="Barbara C." last="Tilley">Barbara C. Tilley</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Shaftman, Stephanie R" sort="Shaftman, Stephanie R" uniqKey="Shaftman S" first="Stephanie R." last="Shaftman">Stephanie R. Shaftman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Fahn, Stanley" sort="Fahn, Stanley" uniqKey="Fahn S" first="Stanley" last="Fahn">Stanley Fahn</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Martinez Martin, Pablo" sort="Martinez Martin, Pablo" uniqKey="Martinez Martin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Neuroepidemiology Unit and CIBERNED, Carlos III Institute of Health</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Poewe, Wemer" sort="Poewe, Wemer" uniqKey="Poewe W" first="Wemer" last="Poewe">Wemer Poewe</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Department of Neurology, Innsbruck Medical University</s1>
<s2>Innsbruck</s2>
<s3>AUT</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Autriche</country>
</affiliation>
</author>
<author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Department of Pharmacology, Faculdade de Medicina de Lisboa</s1>
<s2>Lishoa</s2>
<s3>PRT</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Stem, Matthew B" sort="Stem, Matthew B" uniqKey="Stem M" first="Matthew B." last="Stem">Matthew B. Stem</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Neurology, University of Pennsylvania</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Dodel, Richard" sort="Dodel, Richard" uniqKey="Dodel R" first="Richard" last="Dodel">Richard Dodel</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Neurology, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Department of Neurology, Hôpital de la Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Holloway, Robert" sort="Holloway, Robert" uniqKey="Holloway R" first="Robert" last="Holloway">Robert Holloway</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Department of Neurology, University of Rochester</s1>
<s2>Rochester, New York</s2>
<s3>USA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Department of Neurology, Baylor College of Medicine</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Kulisevsky, Jaime" sort="Kulisevsky, Jaime" uniqKey="Kulisevsky J" first="Jaime" last="Kulisevsky">Jaime Kulisevsky</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Department of Neurology and CIBERNED, Sant Pau Hospital</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Lane, Anthony E" sort="Lane, Anthony E" uniqKey="Lane A" first="Anthony E." last="Lane">Anthony E. Lane</name>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Division of Neurology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Reta Lila Weston Institute of Neurological Studies, University College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Leurgans, Sue" sort="Leurgans, Sue" uniqKey="Leurgans S" first="Sue" last="Leurgans">Sue Leurgans</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Le Witt, Peter A" sort="Le Witt, Peter A" uniqKey="Le Witt P" first="Peter A." last="Le Witt">Peter A. Le Witt</name>
<affiliation wicri:level="1"><inist:fA14 i1="15"><s1>Department of Neurology, Wayne State University</s1>
<s2>Detroit, Michigan</s2>
<s3>USA</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Nyenhuis, David" sort="Nyenhuis, David" uniqKey="Nyenhuis D" first="David" last="Nyenhuis">David Nyenhuis</name>
<affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Deparonent of Neurology and Rehabilitation, University of, Illinois</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
<affiliation wicri:level="1"><inist:fA14 i1="17"><s1>Department of Neurology, Mount Sinai School of Medicine</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="18"><s1>Department of Neuroscience, Mount Sinai School of Medicine</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation wicri:level="1"><inist:fA14 i1="19"><s1>Laboratoire de Pharmacologie Médicale et Clinique, Toulouse University</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
<affiliation wicri:level="1"><inist:fA14 i1="20"><s1>Department of Clinical Neurosciences, University College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Teresi, Jeanne A" sort="Teresi, Jeanne A" uniqKey="Teresi J" first="Jeanne A." last="Teresi">Jeanne A. Teresi</name>
<affiliation wicri:level="1"><inist:fA14 i1="21"><s1>Stroud Center, Division of General Medicine and Psychiatric Institute, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Van Hilten, Jacobus J" sort="Van Hilten, Jacobus J" uniqKey="Van Hilten J" first="Jacobus J." last="Van Hilten">Jacobus J. Van Hilten</name>
<affiliation wicri:level="1"><inist:fA14 i1="22"><s1>Department of Neurology, Leiden University</s1>
<s2>Leiden</s2>
<s3>NLD</s3>
<sZ>24 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Lapelle, Nancy" sort="Lapelle, Nancy" uniqKey="Lapelle N" first="Nancy" last="Lapelle">Nancy Lapelle</name>
<affiliation wicri:level="1"><inist:fA14 i1="23"><s1>Division of Preventive and Behavioral Medicine, University of Massachusetts</s1>
<s2>Worcester, Massachusetts</s2>
<s3>USA</s3>
<sZ>25 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0038025</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 09-0038025 INIST</idno>
<idno type="RBID">Pascal:09-0038025</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001043</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001C76</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results</title>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Tilley, Barbara C" sort="Tilley, Barbara C" uniqKey="Tilley B" first="Barbara C." last="Tilley">Barbara C. Tilley</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Shaftman, Stephanie R" sort="Shaftman, Stephanie R" uniqKey="Shaftman S" first="Stephanie R." last="Shaftman">Stephanie R. Shaftman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Fahn, Stanley" sort="Fahn, Stanley" uniqKey="Fahn S" first="Stanley" last="Fahn">Stanley Fahn</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Martinez Martin, Pablo" sort="Martinez Martin, Pablo" uniqKey="Martinez Martin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Neuroepidemiology Unit and CIBERNED, Carlos III Institute of Health</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Poewe, Wemer" sort="Poewe, Wemer" uniqKey="Poewe W" first="Wemer" last="Poewe">Wemer Poewe</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Department of Neurology, Innsbruck Medical University</s1>
<s2>Innsbruck</s2>
<s3>AUT</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Autriche</country>
</affiliation>
</author>
<author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Department of Pharmacology, Faculdade de Medicina de Lisboa</s1>
<s2>Lishoa</s2>
<s3>PRT</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Portugal</country>
</affiliation>
</author>
<author><name sortKey="Stem, Matthew B" sort="Stem, Matthew B" uniqKey="Stem M" first="Matthew B." last="Stem">Matthew B. Stem</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Neurology, University of Pennsylvania</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Dodel, Richard" sort="Dodel, Richard" uniqKey="Dodel R" first="Richard" last="Dodel">Richard Dodel</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Neurology, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Department of Neurology, Hôpital de la Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Holloway, Robert" sort="Holloway, Robert" uniqKey="Holloway R" first="Robert" last="Holloway">Robert Holloway</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Department of Neurology, University of Rochester</s1>
<s2>Rochester, New York</s2>
<s3>USA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Department of Neurology, Baylor College of Medicine</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Kulisevsky, Jaime" sort="Kulisevsky, Jaime" uniqKey="Kulisevsky J" first="Jaime" last="Kulisevsky">Jaime Kulisevsky</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Department of Neurology and CIBERNED, Sant Pau Hospital</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author><name sortKey="Lane, Anthony E" sort="Lane, Anthony E" uniqKey="Lane A" first="Anthony E." last="Lane">Anthony E. Lane</name>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Division of Neurology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Reta Lila Weston Institute of Neurological Studies, University College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Leurgans, Sue" sort="Leurgans, Sue" uniqKey="Leurgans S" first="Sue" last="Leurgans">Sue Leurgans</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Le Witt, Peter A" sort="Le Witt, Peter A" uniqKey="Le Witt P" first="Peter A." last="Le Witt">Peter A. Le Witt</name>
<affiliation wicri:level="1"><inist:fA14 i1="15"><s1>Department of Neurology, Wayne State University</s1>
<s2>Detroit, Michigan</s2>
<s3>USA</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Nyenhuis, David" sort="Nyenhuis, David" uniqKey="Nyenhuis D" first="David" last="Nyenhuis">David Nyenhuis</name>
<affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Deparonent of Neurology and Rehabilitation, University of, Illinois</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
<affiliation wicri:level="1"><inist:fA14 i1="17"><s1>Department of Neurology, Mount Sinai School of Medicine</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="18"><s1>Department of Neuroscience, Mount Sinai School of Medicine</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation wicri:level="1"><inist:fA14 i1="19"><s1>Laboratoire de Pharmacologie Médicale et Clinique, Toulouse University</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
<affiliation wicri:level="1"><inist:fA14 i1="20"><s1>Department of Clinical Neurosciences, University College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Teresi, Jeanne A" sort="Teresi, Jeanne A" uniqKey="Teresi J" first="Jeanne A." last="Teresi">Jeanne A. Teresi</name>
<affiliation wicri:level="1"><inist:fA14 i1="21"><s1>Stroud Center, Division of General Medicine and Psychiatric Institute, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Van Hilten, Jacobus J" sort="Van Hilten, Jacobus J" uniqKey="Van Hilten J" first="Jacobus J." last="Van Hilten">Jacobus J. Van Hilten</name>
<affiliation wicri:level="1"><inist:fA14 i1="22"><s1>Department of Neurology, Leiden University</s1>
<s2>Leiden</s2>
<s3>NLD</s3>
<sZ>24 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Lapelle, Nancy" sort="Lapelle, Nancy" uniqKey="Lapelle N" first="Nancy" last="Lapelle">Nancy Lapelle</name>
<affiliation wicri:level="1"><inist:fA14 i1="23"><s1>Division of Preventive and Behavioral Medicine, University of Massachusetts</s1>
<s2>Worcester, Massachusetts</s2>
<s3>USA</s3>
<sZ>25 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Evaluation scale</term>
<term>Myelodysplastic syndrome</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Revision</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Syndrome myélodysplasique</term>
<term>Pathologie du   système nerveux</term>
<term>Révision</term>
<term>Echelle d'évaluation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We present a clinimetric assessment of the Movement Disorder Society (MDS)-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UDPRS Task Force revised and expanded the UPDRS using recommendations from a published critique. The MDS-UPDRS has four parts, namely, I: Non-motor Experiences of Daily Living; II: Motor Experiences of Daily Living; III: Motor Examination; IV: Motor Complications. Twenty questions are completed by the patient/caregiver. Item-specific instructions and an appendix of complementary additional scales are provided. Movement disorder specialists and study coordinators administered the UPDRS (55 items) and MDS-UPDRS (65 items) to 877 English speaking (78% non-Latino Caucasian) patients with Parkinson's disease from 39 sites. We compared the two scales using correlative techniques and factor analysis. The MDS-UPDRS showed high intemal consistency (Cronbach's alpha = 0.79-0.93 across parts) and correlated with the original UPDRS (p = 0.96). MDS-UPDRS across-part correlations ranged from 0.22 to 0.66. Reliable factor structures for each part were obtained (comparative fit index > 0.90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>23</s2>
</fA05>
<fA06><s2>15</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>GOETZ (Christopher G.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>TILLEY (Barbara C.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SHAFTMAN (Stephanie R.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>STEBBINS (Glenn T.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>FAHN (Stanley)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>MARTINEZ-MARTIN (Pablo)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>POEWE (Wemer)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>SAMPAIO (Cristina)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>STEM (Matthew B.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>DODEL (Richard)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>DUBOIS (Bruno)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>HOLLOWAY (Robert)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>JANKOVIC (Joseph)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>KULISEVSKY (Jaime)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>LANE (Anthony E.)</s1>
</fA11>
<fA11 i1="16" i2="1"><s1>LEES (Andrew)</s1>
</fA11>
<fA11 i1="17" i2="1"><s1>LEURGANS (Sue)</s1>
</fA11>
<fA11 i1="18" i2="1"><s1>LE WITT (Peter A.)</s1>
</fA11>
<fA11 i1="19" i2="1"><s1>NYENHUIS (David)</s1>
</fA11>
<fA11 i1="20" i2="1"><s1>OLANOW (C. Warren)</s1>
</fA11>
<fA11 i1="21" i2="1"><s1>RASCOL (Olivier)</s1>
</fA11>
<fA11 i1="22" i2="1"><s1>SCHRAG (Anette)</s1>
</fA11>
<fA11 i1="23" i2="1"><s1>TERESI (Jeanne A.)</s1>
</fA11>
<fA11 i1="24" i2="1"><s1>VAN HILTEN (Jacobus J.)</s1>
</fA11>
<fA11 i1="25" i2="1"><s1>LAPELLE (Nancy)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>17 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina</s1>
<s2>Charleston, South Carolina</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Neuroepidemiology Unit and CIBERNED, Carlos III Institute of Health</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Neurology, Innsbruck Medical University</s1>
<s2>Innsbruck</s2>
<s3>AUT</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department of Pharmacology, Faculdade de Medicina de Lisboa</s1>
<s2>Lishoa</s2>
<s3>PRT</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Department of Neurology, University of Pennsylvania</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Department of Neurology, Philipps-University</s1>
<s2>Marburg</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Department of Neurology, Hôpital de la Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Department of Neurology, University of Rochester</s1>
<s2>Rochester, New York</s2>
<s3>USA</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>Department of Neurology, Baylor College of Medicine</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>Department of Neurology and CIBERNED, Sant Pau Hospital</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>Division of Neurology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="14"><s1>Reta Lila Weston Institute of Neurological Studies, University College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA14 i1="15"><s1>Department of Neurology, Wayne State University</s1>
<s2>Detroit, Michigan</s2>
<s3>USA</s3>
<sZ>18 aut.</sZ>
</fA14>
<fA14 i1="16"><s1>Deparonent of Neurology and Rehabilitation, University of, Illinois</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>19 aut.</sZ>
</fA14>
<fA14 i1="17"><s1>Department of Neurology, Mount Sinai School of Medicine</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</fA14>
<fA14 i1="18"><s1>Department of Neuroscience, Mount Sinai School of Medicine</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>20 aut.</sZ>
</fA14>
<fA14 i1="19"><s1>Laboratoire de Pharmacologie Médicale et Clinique, Toulouse University</s1>
<s2>Toulouse</s2>
<s3>FRA</s3>
<sZ>21 aut.</sZ>
</fA14>
<fA14 i1="20"><s1>Department of Clinical Neurosciences, University College</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>22 aut.</sZ>
</fA14>
<fA14 i1="21"><s1>Stroud Center, Division of General Medicine and Psychiatric Institute, Columbia University</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>23 aut.</sZ>
</fA14>
<fA14 i1="22"><s1>Department of Neurology, Leiden University</s1>
<s2>Leiden</s2>
<s3>NLD</s3>
<sZ>24 aut.</sZ>
</fA14>
<fA14 i1="23"><s1>Division of Preventive and Behavioral Medicine, University of Massachusetts</s1>
<s2>Worcester, Massachusetts</s2>
<s3>USA</s3>
<sZ>25 aut.</sZ>
</fA14>
<fA17 i1="01" i2="1"><s1>Movement Disorder Society UPDRS Revision Task Force</s1>
<s3>INC</s3>
</fA17>
<fA20><s1>2129-2170</s1>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000185020710040</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>14 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0038025</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We present a clinimetric assessment of the Movement Disorder Society (MDS)-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UDPRS Task Force revised and expanded the UPDRS using recommendations from a published critique. The MDS-UPDRS has four parts, namely, I: Non-motor Experiences of Daily Living; II: Motor Experiences of Daily Living; III: Motor Examination; IV: Motor Complications. Twenty questions are completed by the patient/caregiver. Item-specific instructions and an appendix of complementary additional scales are provided. Movement disorder specialists and study coordinators administered the UPDRS (55 items) and MDS-UPDRS (65 items) to 877 English speaking (78% non-Latino Caucasian) patients with Parkinson's disease from 39 sites. We compared the two scales using correlative techniques and factor analysis. The MDS-UPDRS showed high intemal consistency (Cronbach's alpha = 0.79-0.93 across parts) and correlated with the original UPDRS (p = 0.96). MDS-UPDRS across-part correlations ranged from 0.22 to 0.66. Reliable factor structures for each part were obtained (comparative fit index > 0.90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Syndrome myélodysplasique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Myelodysplastic syndrome</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Mielodisplastico síndrome</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Révision</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Revision</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Revisión</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Echelle d'évaluation</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Evaluation scale</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Escala evaluación</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Hémopathie maligne</s0>
<s2>NM</s2>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Malignant hemopathy</s0>
<s2>NM</s2>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Hemopatía maligna</s0>
<s2>NM</s2>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fN21><s1>026</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C76 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001C76 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:09-0038025
   |texte=   Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results

Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri